Epilepsy, Lennox-Gastaut

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf epileptic syndrome
gptkbp:abbreviation gptkb:LGS
gptkbp:affects adolescents
children
adults (rarely)
gptkbp:alsoKnownAs gptkb:Lennox-Gastaut_syndrome
gptkbp:associatedWith intellectual disability
developmental delay
behavioral problems
gptkbp:characterizedBy cognitive impairment
multiple seizure types
slow spike-and-wave EEG pattern
gptkbp:commonSeizureTypes atonic seizures
myoclonic seizures
generalized tonic-clonic seizures
atypical absence seizures
tonic seizures
gptkbp:EEGPattern slow spike-and-wave (1.5–2.5 Hz)
gptkbp:etiology genetic causes
structural brain abnormalities
diverse causes
unknown in some cases
gptkbp:firstDescribed 1966
gptkbp:hasOrphanetID ORPHA:2386
https://www.w3.org/2000/01/rdf-schema#label Epilepsy, Lennox-Gastaut
gptkbp:ICD-10_code G40.4
gptkbp:MeSH_ID D007566
gptkbp:mortalityRate higher than other epilepsies
gptkbp:namedAfter Henri Gastaut
William G. Lennox
gptkbp:OMIM 606369
gptkbp:onset childhood
between 3 and 5 years
gptkbp:prevalence rare
1-2% of all childhood epilepsies
gptkbp:prognosis often poor
seizures often persist into adulthood
gptkbp:riskFactor high
gptkbp:seizureControl often difficult
gptkbp:seizureFrequency frequent
gptkbp:treatment gptkb:valproic_acid
gptkb:ketogenic_diet
gptkb:vagus_nerve_stimulation
gptkb:lamotrigine
gptkb:topiramate
gptkb:corpus_callosotomy
cannabidiol
antiepileptic drugs
felbamate
clobazam
rufinamide
gptkbp:bfsParent gptkb:D004239
gptkbp:bfsLayer 8